[{"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-001", "question": "A 68-year-old man with a history of severe COPD (FEV1 35% predicted) and chronic hypercapnia (baseline PaCO2 55 mmHg) presents with acute-on-chronic hypercapnic respiratory failure requiring non-invasive ventilation. After 48 hours of improvement, his arterial blood gas shows pH 7.36, PaCO2 48 mmHg, PaO2 85 mmHg on 2 L/min nasal cannula. He is alert and comfortable. The next most appropriate step in management is:", "options": ["Gradually wean and discontinue supplemental oxygen to target a PaO2 of 55-60 mmHg", "Continue current oxygen therapy and plan for discharge home with home oxygen", "Increase oxygen flow to achieve a PaO2 > 88 mmHg", "Obtain a venous blood gas to confirm the arterial values", "Initiate acetazolamide 250 mg twice daily to accelerate renal compensation"], "answer": "A", "answer_index": 0, "explanation": "In patients with chronic hypercapnia, the hypoxic drive is a primary respiratory stimulus. Over-oxygenation can suppress this drive, leading to worsening hypercapnia and acidosis. The target PaO2 is 55-60 mmHg or SpO2 88-92%, which provides adequate oxygenation while minimizing the risk of CO2 retention. Increasing oxygen (C) is dangerous, and acetazolamide (E) is not indicated in acute-on-chronic respiratory failure as it can worsen acidosis by inhibiting compensatory metabolic alkalosis.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "In a patient with severe COPD and chronic hypercapnia, excessive oxygen can suppress hypoxic drive and worsen hypercapnia.  \nHis current ABG shows acceptable pH and PaCO₂ near his baseline, with PaO₂ 85 mmHg on low-flow oxygen.  \nFor chronic hypercapnic respiratory failure, the goal is to maintain PaO₂ around 55–60 mmHg or SpO₂ 88–92% to avoid oxygen-induced hypercapnia.  \nHere, PaO₂ 85 mmHg is higher than needed and risks delaying resolution of hypercapnia.  \nThe best step is to titrate oxygen down to a safer target range.  \n\nThe answer is A"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-002", "question": "A 45-year-old woman with a history of recurrent calcium oxalate kidney stones presents with acute pancreatitis. Lipase is 1200 U/L, calcium 11.8 mg/dL, PTH 85 pg/mL (normal 10-65). She is not on lithium or thiazides. A pancreatic protocol CT shows diffuse gland enlargement but no necrosis or ductal dilation. The most likely underlying etiology of her pancreatitis is:", "options": ["Primary hyperparathyroidism due to parathyroid adenoma", "Autoimmune pancreatitis (IgG4-related disease)", "Hereditary pancreatitis due to PRSS1 mutation", "Hypertriglyceridemia-induced pancreatitis", "Pancreatitis secondary to a gastrinoma (Zollinger-Ellison syndrome)"], "answer": "A", "answer_index": 0, "explanation": "The triad of hypercalcemia, elevated PTH, and recurrent calcium oxalate stones is classic for primary hyperparathyroidism. Hypercalcemia is a known, though uncommon, cause of pancreatitis. The elevated PTH confirms primary hyperparathyroidism, not secondary causes. While hypertriglyceridemia (D) can cause pancreatitis, it doesn't explain the hypercalcemia and elevated PTH. Gastrinoma (E) is associated with ulcers and diarrhea, not typically hypercalcemia and stones.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has hypercalcemia (11.8 mg/dL) with elevated PTH (85 pg/mL), consistent with primary hyperparathyroidism.  \nHypercalcemia is a known but uncommon cause of pancreatitis, and the patient’s history of recurrent calcium oxalate stones further supports primary hyperparathyroidism as the underlying condition.  \nOther options are less likely given the lab findings:  \n- Autoimmune pancreatitis (B) typically presents with different imaging features (sausage-shaped pancreas, capsule-like rim) and often elevated IgG4, not mentioned here.  \n- Hereditary pancreatitis (C) usually presents earlier in life and without this pattern of hypercalcemia/high PTH.  \n- Hypertriglyceridemia (D) would likely show very high triglycerides, not mentioned.  \n- Gastrinoma (E) causes ulcers and diarrhea, not typically hypercalcemia with high PTH.  \n\nThe answer is A"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-003", "question": "A 32-year-old woman presents with 3 weeks of progressive dyspnea and fatigue. Echocardiogram shows a large pericardial effusion with diastolic right atrial and right ventricular collapse. Right heart catheterization reveals equalization of diastolic pressures (RA 18, RV 18, PA 18/20, PCWP 18 mmHg). After pericardiocentesis of 800 mL of serosanguinous fluid, hemodynamics improve. Cytology is negative. Two days later, she develops recurrent dyspnea. Repeat echo shows reaccumulation of the effusion. The most appropriate definitive management is:", "options": ["Repeat pericardiocentesis and initiate colchicine", "Surgical creation of a pericardial window via subxiphoid approach", "Initiation of high-dose prednisone for suspected autoimmune pericarditis", "Pericardiectomy via left thoracotomy", "Intrapericardial instillation of bleomycin"], "answer": "B", "answer_index": 1, "explanation": "Recurrent symptomatic pericardial effusion with tamponade physiology, especially when cytology is negative (ruling out malignancy requiring specific therapy), is a clear indication for a definitive surgical procedure to prevent reaccumulation. A surgical pericardial window (subxiphoid or video-assisted) allows for drainage and biopsy. Pericardiectomy (D) is reserved for constrictive pericarditis. Steroids (C) are for inflammatory causes but are not definitive for recurrent effusion. Intrapericardial chemotherapy (E) is for malignant effusions.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient has cardiac tamponade with rapid reaccumulation of serosanguinous fluid after pericardiocentesis, suggesting a malignant or inflammatory effusion, though cytology is negative.  \nRecurrent tamponade with rapid reaccumulation despite drainage is an indication for a definitive procedure to prevent recurrence.  \nA surgical pericardial window via subxiphoid approach allows drainage into the pleural/peritoneal space and is the standard next step for recurrent effusions when malignancy or other causes are suspected and cytology is negative.  \n\nThe answer is B"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-004", "question": "A 70-year-old man with atrial fibrillation on apixaban (non-valvular) presents with acute onset of right-sided weakness and aphasia 4 hours after symptom onset. NIHSS is 15. CT head shows no hemorrhage. He is not a candidate for IV tPA due to anticoagulation. CT angiography shows a left M1 MCA occlusion. The most appropriate acute intervention is:", "options": ["Administer IV tPA after checking an INR and anti-Xa level", "Proceed directly to mechanical thrombectomy without thrombolysis", "Administer IV protamine to reverse apixaban, then give IV tPA", "Administer andexanet alfa, then give IV tPA", "Initiate IV heparin drip and observe for neurological improvement"], "answer": "B", "answer_index": 1, "explanation": "For patients with acute ischemic stroke and large vessel occlusion (LVO) who are not candidates for IV tPA, mechanical thrombectomy is the standard of care if performed within 24 hours of last known well and meeting other criteria (like NIHSS ≥6). Direct thrombectomy is non-inferior to bridging therapy (tPA + thrombectomy). Reversing anticoagulation to give tPA (C, D) delays definitive therapy and adds bleeding risk. Giving tPA on top of therapeutic anticoagulation (A) is contraindicated.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The scenario specifies the patient is on apixaban (a direct oral anticoagulant) and is not a candidate for IV tPA due to anticoagulation.  \nCT shows no hemorrhage and angiography confirms a large vessel occlusion (left M1).  \n\nCurrent guidelines for acute ischemic stroke with large vessel occlusion in a patient taking DOACs, when IV tPA is contraindicated due to anticoagulation, recommend proceeding directly to mechanical thrombectomy if it can be done within the appropriate time window (which here is within 4 hours of onset, making thrombectomy indicated).  \n\nReversal agents (andexanet alfa) are not routinely given prior to thrombectomy unless there is active bleeding, and giving tPA after reversal is not standard in this emergency setting due to delay and lack of evidence.  \n\nThe most appropriate acute intervention is mechanical thrombectomy without thrombolysis.  \n\nThe answer is B"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-005", "question": "A 55-year-old man with alcoholic cirrhosis (Child-Pugh B) is admitted with hepatic encephalopathy. He is started on lactulose. On day 3, he develops acute kidney injury. Serum sodium is 122 mEq/L (down from 128 on admission), creatinine 2.4 mg/dL (baseline 0.9), and he is clinically envolemic. Urine sodium is <10 mEq/L, urine osmolality 550 mOsm/kg. The most likely cause of his hyponatremia is:", "options": ["Syndrome of inappropriate antidiuretic hormone secretion (SIADH)", "Acute tubular necrosis from sepsis", "Hepatorenal syndrome type 1", "Pseudohyponatremia from hypertriglyceridemia", "Hyponatremia due to lactulose-induced diarrhea"], "answer": "E", "answer_index": 4, "explanation": "Lactulose causes an osmotic diarrhea, leading to loss of sodium and water, but relatively more water loss, resulting in hypertonic hyponatremia. The clinical picture (envolemic, high urine osmolality, low urine sodium) is consistent with volume depletion from GI losses, not SIADH (which has inappropriately high urine sodium). Hepatorenal syndrome (C) is characterized by low urine sodium but typically occurs in the setting of avid sodium retention and ascites, not acute diarrhea. ATN (B) would have high urine sodium.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has cirrhosis with acute kidney injury, hyponatremia, low urine sodium (<10 mEq/L), high urine osmolality (550 mOsm/kg), and is clinically euvolemic.  \nIn cirrhosis, hepatorenal syndrome type 1 is characterized by rapidly progressive renal failure, low urine sodium, high urine osmolality, and absence of other causes, often triggered by events like infection or gastrointestinal bleeding, but here the scenario fits with cirrhosis-related hemodynamic changes leading to renal vasoconstriction.  \nSIADH would have high urine sodium, not low.  \nAcute tubular necrosis usually has high urine sodium.  \nPseudohyponatremia would not cause true low serum sodium by direct measurement in this context.  \nLactulose-induced diarrhea could cause hypovolemic hyponatremia with low urine sodium, but the patient is euvolemic, and in cirrhosis the most likely euvolemic/low-effective-arterial-blood-volume hyponatremia with AKI is hepatorenal syndrome.  \n\nThe answer is (C)"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-006", "question": "A 28-year-old pregnant woman at 32 weeks gestation is admitted for severe preeclampsia with BP 170/110 mmHg. She is started on IV magnesium sulfate for seizure prophylaxis and IV labetalol for blood pressure control. One hour after initiation of magnesium, she becomes somnolent, with loss of deep tendon reflexes. Respiratory rate is 8 breaths/min. Serum magnesium level is 9.2 mg/dL. After securing the airway, the most specific immediate treatment is:", "options": ["IV administration of 10% calcium gluconate 1 gram over 10 minutes", "IV administration of furosemide 40 mg to enhance renal excretion", "Immediate hemodialysis", "Discontinuation of magnesium sulfate and administration of IV levothyroxine", "IV administration of pyridostigmine 2 mg"], "answer": "A", "answer_index": 0, "explanation": "Calcium gluconate is the direct antagonist to the life-threatening cardiac and neuromuscular effects of hypermagnesemia. It stabilizes cardiac membranes and reverses respiratory depression caused by magnesium. Furosemide (B) promotes excretion but is not immediate. Dialysis (C) is for severe cases with renal failure but is not the first step after airway management. Pyridostigmine (E) is for myasthenia, not magnesium toxicity.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has magnesium toxicity, evidenced by loss of reflexes, respiratory depression, and a high serum magnesium level (normal therapeutic range for preeclampsia is 4–8 mg/dL).  \nThe specific antidote for magnesium toxicity is calcium, which antagonizes magnesium’s effects at the neuromuscular junction.  \nIV calcium gluconate is the immediate treatment after airway protection.  \n\nThe answer is (A)"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-007", "question": "A 62-year-old man with a history of asbestos exposure 30 years ago presents with unilateral right-sided pleural effusion. Thoracentesis reveals exudative fluid (by Light's criteria) with cytology positive for adenocarcinoma. PET-CT shows FDG-avid right pleural thickening and effusion, with no other distant metastases. The next best step in management is:", "options": ["Systemic chemotherapy with platinum-pemetrexed", "Pleurodesis followed by systemic chemotherapy", "Extrapleural pneumonectomy", "Pleurectomy/decortication followed by adjuvant chemoradiation", "Immunotherapy with pembrolizumab as first-line treatment"], "answer": "D", "answer_index": 3, "explanation": "This describes a likely diagnosis of malignant pleural mesothelioma (given asbestos exposure, unilateral effusion, pleural thickening). For resectable disease (stage I-III) in a fit patient, the standard of care is maximal cytoreductive surgery (pleurectomy/decortication) followed by adjuvant chemotherapy and possibly radiation. Extrapleural pneumonectomy (C) is a more radical, less commonly performed option. Systemic therapy alone (A) is for unresectable disease. Pleurodesis (B) is palliative.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "The patient has a unilateral pleural effusion with adenocarcinoma, consistent with malignant pleural mesothelioma or metastatic adenocarcinoma.  \nGiven the asbestos exposure history and presentation, malignant pleural mesothelioma is likely.  \nFor resectable malignant pleural mesothelioma without distant metastases (as suggested by PET-CT), the standard of care is multimodal therapy with surgery (either pleurectomy/decortication or extrapleural pneumonectomy) combined with chemotherapy ± radiation.  \nExtrapleural pneumonectomy is less favored now due to morbidity, and pleurectomy/decortication is preferred for macroscopic complete resection.  \nAdjuvant chemoradiation often follows.  \nSystemic chemotherapy alone (A) or immunotherapy alone (E) would not be first-line for resectable disease. Pleurodesis (B) is palliative, not curative.  \nBetween C and D, pleurectomy/decortication is currently the preferred surgical approach.  \n\nThe answer is D"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-008", "question": "A 40-year-old woman presents with palpitations, heat intolerance, and weight loss. TSH is <0.01 mIU/L, free T4 is 3.2 ng/dL (high). Thyroid ultrasound shows a 2 cm hypoechoic nodule in the right lobe. Radioactive iodine uptake scan shows diffusely increased uptake (45% at 24 hours) with a photopenic area corresponding to the nodule. The most likely diagnosis is:", "options": ["Graves' disease with a coexisting cold nodule", "Toxic multinodular goiter", "Subacute thyroiditis", "Factitious thyrotoxicosis", "Marine-Lenhart syndrome (Graves' disease with a functioning nodule)"], "answer": "A", "answer_index": 0, "explanation": "The diffusely increased uptake is diagnostic of Graves' disease. The photopenic ('cold') nodule within an area of diffusely high uptake indicates a non-functioning nodule, which raises concern for malignancy and requires FNA biopsy. Marine-Lenhart syndrome (E) is Graves' with a *functioning* (hot) nodule. Toxic MNG (B) would show multiple areas of increased uptake. Subacute thyroiditis (C) shows very low uptake.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has biochemical hyperthyroidism with a low TSH and high free T4.  \nThe radioactive iodine uptake scan shows **diffusely increased uptake** (consistent with Graves’ disease) but with a **photopenic area** corresponding to the nodule seen on ultrasound.  \n\nA photopenic (“cold”) nodule in the setting of diffusely increased uptake means the nodule is not taking up iodine like the rest of the gland. This suggests Graves’ disease with a coexisting nonfunctioning (cold) nodule, which could be a benign adenoma, cyst, or possibly thyroid cancer.  \n\nMarine-Lenhart syndrome (E) refers to Graves’ disease with **one or more functioning (hot) nodules** appearing on a background of diffusely increased uptake, but here the nodule is photopenic, so that’s not correct.  \n\nThe best answer is **Graves’ disease with a coexisting cold nodule**.  \n\n**The answer is (A)**"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-009", "question": "A 50-year-old man with diabetes mellitus and hypertension is found to have a serum potassium of 6.8 mEq/L on routine labs. He is asymptomatic. ECG shows peaked T waves. He is given IV calcium gluconate, insulin/dextrose, and albuterol. His potassium decreases to 6.0 mEq/L. Renal function is normal. Further workup reveals a low serum aldosterone and elevated plasma renin activity. The most likely cause of his hyperkalemia is:", "options": ["Type 4 renal tubular acidosis (hyporeninemic hypoaldosteronism)", "Addison's disease", "Gordon's syndrome (pseudohypoaldosteronism type II)", "Spironolactone use", "Rhabdomyolysis"], "answer": "C", "answer_index": 2, "explanation": "Gordon's syndrome (familial hyperkalemic hypertension) is characterized by hyperkalemia, hypertension, normal GFR, metabolic acidosis, and *suppressed* renin but *normal or high* aldosterone. The key here is the elevated renin, which rules out hyporeninemic hypoaldosteronism (A, which has low renin and low aldosterone) and points to a primary renal defect in potassium excretion. Addison's (B) has low aldosterone and high renin but also has hyponatremia and hypotension.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "Let’s break this down:  \n\n- The patient has **hyperkalemia** with **normal renal function**, **low aldosterone**, and **elevated plasma renin activity**.  \n- In **Type 4 RTA** (hyporeninemic hypoaldosteronism), renin is **low or normal**, not elevated.  \n- **Addison’s disease** → low aldosterone, high renin (due to low cortisol and aldosterone) — fits biochemically.  \n- **Gordon’s syndrome** → hypertension, hyperkalemia, but aldosterone is **suppressed due to volume expansion** and renin is **low** (not elevated).  \n- **Spironolactone** → would cause high renin and high aldosterone (blocked action, so aldosterone increases).  \n- **Rhabdomyolysis** → hyperkalemia from cell breakdown, but renin/aldosterone not primarily affected like this.  \n\nElevated renin + low aldosterone in a hypertensive diabetic with normal renal function points toward **primary adrenal insufficiency (Addison’s)** affecting aldosterone more than renin response.  \n\n**The answer is B.**  \n\nThe answer is (B)"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-010", "question": "A 65-year-old man with a mechanical aortic valve (On-X) on warfarin presents with a transient ischemic attack. INR on presentation is 1.8 (target 2.5-3.5). He has no bleeding history. The most appropriate adjustment to his antithrombotic regimen is:", "options": ["Increase warfarin dose to achieve INR 2.5-3.5; add aspirin 81 mg daily", "Increase warfarin dose to achieve INR 2.5-3.5; no aspirin needed", "Switch to apixaban 5 mg twice daily", "Add clopidogrel 75 mg daily to current warfarin therapy", "Discontinue warfarin and initiate dual antiplatelet therapy with aspirin and clopidogrel"], "answer": "A", "answer_index": 0, "explanation": "For a mechanical aortic valve, the standard of care is warfarin with a target INR of 2.5-3.5. In patients who have a thromboembolic event despite therapeutic INR, adding aspirin 75-100 mg is recommended. Since his INR was subtherapeutic at the time of the TIA, the first step is to optimize INR control. However, given the event, adding low-dose aspirin is now indicated based on PROACT and other trials. Direct oral anticoagulants (C) are contraindicated in mechanical valves. Dual antiplatelet therapy (E) is inferior to warfarin for valve protection.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "The patient has a mechanical aortic valve (specifically On-X) and experienced a TIA while subtherapeutic on warfarin (INR 1.8, target 2.5–3.5).  \n\nFor mechanical aortic valves, especially On-X, guidelines recommend warfarin with a target INR of 2.0–3.0 or 2.5–3.5 depending on valve model and patient risk factors. After a thromboembolic event while subtherapeutic, the appropriate step is to resume therapeutic anticoagulation with warfarin.  \n\nAdding aspirin (81–100 mg daily) to warfarin is recommended for patients with mechanical heart valves who have additional risk factors (prior thromboembolism, older-generation valve, mitral position, atrial fibrillation, or hypercoagulable state). Here, the TIA while subtherapeutic suggests increased risk, so adding low-dose aspirin is reasonable per ACC/AHA guidelines.  \n\nOption A includes both dose adjustment to achieve target INR and adding aspirin 81 mg daily, which matches current standard of care for a patient with a mechanical valve and a thromboembolic event.  \n\nOption B omits aspirin, which is less protective in this higher-risk scenario.  \nOption C (apixaban) is contraindicated in mechanical valves (DOACs not approved except in limited trial settings).  \nOption D (adding clopidogrel) is not standard first-line.  \nOption E (stopping warfarin) is incorrect because mechanical valves require lifelong vitamin K antagonist therapy.  \n\n**The answer is A**  \n\nThe answer is (A)"}]